Best Healthcare Companies in South Korea
The 517 best Healthcare companies in South Korea in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Kering.
South Korea's Healthcare sector has 517 companies on our radar, with $357M in total disclosed funding spread across a field that's still pre-unicorn but clearly building momentum. The global market hit roughly $2T in 2020 and is tracking toward $2.6T by 2025 at a 6.3% CAGR, driven largely by virtual touchpoints and consumer demand for affordable, tech-enabled care. Kering leads our directory at $58M in disclosed equity, with TiumBio at $32M and Pangen Biotech at $10M rounding out the funded tier. Korea Investment Holdings, Aju IB Investment, and Company K Partners are the most active capital sources here, which tells you something about where conviction is forming.
What's the live theme right now? Vaccine development. Vaccine candidates, trials, and immunogenicity are dominating sector conversation even as overall funding coverage stays relatively flat. And median app install growth across healthcare and life sciences is running at roughly +16% YoY across 53 tracked apps, so digital distribution is quietly compounding. Strict product safety compliance remains the structural constraint every company here has to price in. Even managed care models are expanding revenue retention strategies as the broader sector figures out sustainable growth, and I think that pressure will hit South Korea's mid-tier cohort especially hard over the next few quarters.
- Global Healthcare to Soar Above $2 Trillion in 2020 with Consumerism a
- Healthcare Consumers in Asia-Pacific Prefer a Single Touchpoint
Ranked: Best Healthcare companies in South Korea
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Kering Provider of home care services for elderly people | $58M | 1 mo ago | 20 | 2018 | — | Node.jsReactNext.js+17 | — | — |
| 2 | CareLabs Provider of healthcare platforms, medical information services, and customer management software | $49M | 42 mo ago | 73 | 2012 | Jonghyun Shin CEO | — | 6 patents Healthcare IT platforms for hospital management, scheduling, location-based services, and post‑care. | — |
| 3 | Organoid Sciences Developer of regenerative medicines for multiple diseases | $39M | 53 mo ago | 70 | 2019 | Jongman Yoo CEO | WordPressMySQLPHP+22 | — | — |
| 4 | Prestige Biologics CDMO focused on manufacturing of biologics and commercialization services | $35M | 39 mo ago | 186 | 2015 | — | — | 33 patents Antibody biomanufacturing: culture, purification, aseptic connections, and AI monitoring systems | 1 partnership |
| 5 | TiumBio Developer of small molecules therapeutics | $32M | 29 mo ago | 51 | 2016 | Kim Hun-Taek CEO | PHPGSAPApache HTTP Server+10 | 60 patents Patents concentrated in chemistry & materials | 2 job openings |
| 6 | LISCure Developer of bacteria-mediated immunotherapeutic drugs for multiple diseases | $26M | 63 mo ago | 7 | 2018 | Hwaseop Chin CEO | — | — | — |
| 7 | MARK-B Provider of automated electrochemical immunoassay systems | $20M | 91 mo ago | — | 2014 | Jaekyu Choi Co-Founder & CEO | — | 5 patents Micro‑LED transfer equipment/methods for high‑resolution and stretchable displays, plus gel‑cutting tools. | — |
| 8 | Cenacle Provider of healthcare strategic consulting services | $18M | 39 mo ago | 56 | 2018 | Park Chan-hee CEO | — | — | — |
| 9 | Future Medicine Developer of therapies for treating inflammation, fibrosis, and cancer | $11M | 85 mo ago | 18 | 2015 | Wan Seok Jeong CEO | — | 116 patents Patents concentrated in health & consumer products | — |
| 10 | Pangen Biotech Developer of biosimilars and biologics | $10M | 19 mo ago | 76 | 2010 | Jae Jang President & CEO | — | 43 patents Lipid nanoparticle protein delivery systems and ophthalmic drug formulations | — |
| 11 | ImmunoBiome Developer of microbiome therapeutics for autoimmunity, cancer, and autism spectrum disorders | $10M | 60 mo ago | 23 | 2019 | Sin-Hyeog Im CEO | — | 33 patents Patents concentrated in health & consumer products | — |
| 12 | ALDAVER Provider of medical education services | $8M | 18 mo ago | 12 | 2021 | Steve Park Co-CEO | GnuboardCart FunctionalityMySQL+18 | 29 patents Medical simulation using 3D‑printed hydrogel tissue phantoms for surgical training | — |
| 13 | Himedi Provider of medical tourism services | $7M | 73 mo ago | 22 | 2011 | — | Cart FunctionalityShopifyVisa+19 | — | 1 expansion |
| 14 | Proxy Healthcare Manufacturer of oral, skin care & pet care products | $6M | 27 mo ago | — | 2019 | Kim Young-Wook CEO | — | — | — |
| 15 | VET HONORS Chain of animal hospitals | $6M | 49 mo ago | 29 | 2021 | Seo Sang-hyeok CEO | ImwebFroala EditorNaver Maps+23 | — | — |
| 16 | ROWAN Provider of big data analytics services | $5M | 52 mo ago | — | 2020 | — | — | 36 patents AI‑driven digital therapeutics for tinnitus management and health assessment via skeletal modeling | — |
| 17 | PRIMORIS Provider of exosome-based aesthetic solutions, derma cosmetics, and raw materials | $5M | 64 mo ago | 9 | 2017 | — | PHPYouTubeApache HTTP Server+10 | 15 patents Exosome and stem‑cell‑derived extracellular vesicle therapeutics for drug delivery | — |
| 18 | SLEEK Standalone fitness and wellness center | $3M | 73 mo ago | 12 | 2017 | — | — | — | — |
| 19 | Novacell Tech Manufacturer of small molecules & peptides | $3M | 73 mo ago | — | 2000 | Taehoon Lee CEO | — | — | — |
| 20 | GLOUD Provider of digital treatment transition services for dental clinics | $2M | 13 mo ago | — | 2020 | Jinwoo Ji Founder & CEO | — | 14 patents Patents concentrated in computing, sensing & instrumentation | — |
| 21 | Bredis Healthcare Developer of AI-powered diagnostic tools for Alzheimer's disease. | $1M | 33 mo ago | 8 | 2023 | Hyundoo Hwang Chief Executive Officer | Wix eCommerceWixSentry+13 | 17 patents Patents concentrated in computing, sensing & instrumentation | — |
| 22 | Tim Buffett Standalone physical fitness center | $1M | 84 mo ago | 58 | 2017 | Minwoo Jang Co-Founder & CEO | Node.jsMUIReact+19 | — | — |
| 23 | injewelme Developer of AI technology for personal data analysis and insights | $1M | 2 mo ago | 9 | 2020 | — | — | 2 patents AI-powered personalized nutrition and obesity management platforms | — |
| 24 | Biobytes Developer of biomarker discovery tools based on sarcopenia biobank cohort | $427K | 19 mo ago | — | 2023 | Lee Jung-woo Founder & CEO | Node.jsUbuntuVideoJS+16 | 5 patents AI-based predictive analytics for sarcopenia and surgical site infection risk assessment | — |
| 25 | Kangsters Manufacturer of wheelchair & washing devices | $100K | 36 mo ago | 9 | 2020 | — | Google MapsBootstrapGoogle Cloud+20 | 14 patents Integrated wheelchair treadmill systems for posture correction and rehabilitation of lower‑extremity disabled users. | — |
Top 12 Healthcare companies in South Korea
#1
Series C · Seoul, Seoul · founded 2018 · 20 employees$57.6Mraised▾
Provider of home care services for elderly people
- May 2026Series C$27.5M
- Feb 2024Series B$30M
#2
Seed · South Korea · founded 2020 · 9 employees$1.2Mraised▾
Developer of AI technology for personal data analysis and insights. The company focuses on extracting value from daily life data streams. It aims to provide individuals with a deeper understanding of their own data. The company builds AI with a human-centric approach.
- Apr 2026Seed$1.2M
#3
Public · Gyeongju si, North Gyeongsang Province · founded 2010 · 76 employees$10.2Mraised▾
Pangen Biotech is a developer of biosimilars and biologics. The products developed are EPO, Factor VIII, G-CSF, and biologics. The company focuses on the development and commercialization of the products.
- Nov 2024Post IPO$10.2M
- Nov 2022Post IPO—
#4
Series A · Daejeon, Daejeon · founded 2021 · 12 employees$7.8Mraised▾
Provider of medical education services
- Dec 2024Series A$7.8M
#5
Series A · Daegu, Daegu · founded 2020$2.2Mraised▾
Provider of digital treatment transition services for dental clinics
- May 2025Series A$6.2M
- Apr 2024Seed$2.2M
#6
Public · Seongnam-si, Gyeonggi-do · founded 2016 · 51 employees$32Mraised▾
TiumBio has developed small molecules and biomolecules for the treatment of cancer, diabetes & rare diseases. The small molecules portfolio includes NCE401 (ALK5 inhibitor for cancer immunotherapy and IPF in preclinical stage), NCE403 (GnRH antagonist for prostate cancer and endometriosis in Phase 1 stage), NCE406 (Type 2 Diabetes mellitus in preclinical stage). Biopharmaceuticals include NBP604 (Recombinant factor VIIa) for hemophilia is in the preclinical stage, NBP611 (hemophilia) and NBP (hemophilia and rare disease) in the discovery stages.
- Jan 2024Post IPO$12M
- Dec 2023Post IPO$29.9M
- May 2018Series B$21.8M
- 2017Series A$10.2M
#7
Acquired · Seoul, Seoul · founded 2012 · 73 employees$48.7Mraised▾
Provider of healthcare platforms, medical information services, and customer management software. The company delivers digital marketing solutions and software optimized for beauty hospitals. It also offers an application for cancer patients and their caregivers, providing community and consultation features.
- Nov 2022Post IPO$48.7M
#8
Series C · Cheongju-si, Chungcheongbuk-do · founded 2015 · 186 employees$34.8Mraised▾
CDMO focused on manufacturing of biologics and commercialization services
- Mar 2023Series C$34.8M
#9
Acquired · Seoul, Seoul · founded 2018 · 56 employees$17.8Mraised▾
Provider of healthcare strategic consulting services
- Feb 2023Series C$15.2M
- Jan 2020Seed$2.6M
- Jan 2019Seed—
#10
Public · Seongnam-si, Gyeonggi-do · founded 2019 · 70 employees$39Mraised▾
Organoid Sciences is a developer of regenerative medicines for multiple diseases. It uses cannabinoid-based technology for the development of a regenerative medicine pipeline.
- Jan 2022Series B$32.5M
- Mar 2020Series A$6.4M
#11
Series A · Ulsan, Ulsan · founded 2019$6.2Mraised▾
Manufacturer of oral, skin care & pet care products
- Feb 2024Series A—
- Aug 2022Series A$6.2M
#12
Seed · Wonju si, Gangwon Province · founded 2023$426.9Kraised▾
Developer of biomarker discovery tools based on sarcopenia biobank cohort. The company specializes in biomarker discovery related to sarcopenia. It offers services including MyoTest and M-Bank. The company welcomes collaborations with other companies for research and development.
- Nov 2024Seed$426.9K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.